Загрузка...
Acute promyelocytic leukemia (APL): remaining challenges towards a cure for all
The application of all-trans retinoic acid (ATRA) and arsenic trioxide (ATO) has revolutionized the treatment of acute promyelocytic leukemia (APL). More than 80–90% of patients are expected to be cured with a combination of ATRA, ATO and/or chemotherapy. In this review, we focus on the remaining ob...
Сохранить в:
| Опубликовано в: : | Leuk Lymphoma |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7479633/ https://ncbi.nlm.nih.gov/pubmed/31842650 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428194.2019.1613540 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|